PATIENT CHARACTERISTICS AND RISK FACTORS FOR MORTALITY IN 504 HOSPITALIZED PATIENTS DUE TO COVID-19

被引:0
作者
Medetalibeyoglu, Alpay [1 ]
Ezirmik, Elif [2 ]
Senkal, Naci [1 ]
Bayrakdar, Sena [3 ]
Aktar, Irem [3 ]
Akas, Reyhan [3 ]
Yilmaz, Ebru [3 ]
Arici, Huzeyfe [1 ]
Kose, Murat [1 ]
Akpinar, Timur [1 ]
Cagatay, Atahan [4 ]
Tukek, Tufan [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Med, Dept Publ Hlth, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Bachelor Med Student, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Fac Med, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey
来源
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI | 2021年
关键词
COVID-19; mortality; admission to intensive care unit; COVID-19 risk factors;
D O I
10.26650/IUITFD.2021.934417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In this study, we aimed to analyze the demographic characteristics, symptoms, and comorbidities of 504 patients hospitalized for COVID-19. We also sought to describe the relationship between these features and intensive care unit (ICU) admission and mortality. Material and Methods: This study is a descriptive study involving 504 COVID-19 patients hospitalized between 16.03.2020 and 07.05.2020 at Istanbul University's Faculty of Medicine Hospital. Information about the patients was obtained from the hospital automation system and evaluated retrospectively. Results: The average age of the 504 patients was 56 +/- 15.14, and 59.1% of them were male. The proportion of the patients admitted into ICU 11.9% and for 8.52% of them the disease resulted in death. Real time polymerase chain reaction (RT-PCR) test results were positive for 60.5% of the patients. The median time spent in the hospital was eight days. Fifty six percent of the patients had at least one accompanying comorbid disease, with hypertension (39.3%) and diabetes (20.8%) being the most common. Being 65 years old or older (p<0.001), days spent in the hospital (p<0.001), presence of at least one comorbidity (p=0.009), hypertension (p=0.003), coronary artery disease (p=0.004), congestive heart failure (p=0.005) and dyspnea (p<0.001) were all factors found in those admitted to ICU. Conclusion: COVID-19 infection leading to high morbidity-mortality rates and an increased requirement for ICU admission is mainly seen among older patients and those who have dyspnea. During the process of analyzing patients suspected of COVID-19 who are admitted to hospital, it is crucial to consider both the patient's age and any respiratory symptoms. Such a clinical evaluation is crucial for a better understanding of the course of the disease.
引用
收藏
页数:8
相关论文
共 38 条
[1]   Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States [J].
Abdollahi, Elaheh ;
Champredon, David ;
Langley, Joanne M. ;
Galvani, Alison P. ;
Moghadas, Seyed M. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (25) :E666-E670
[2]   Risk factors for mortality among COVID-19 patients [J].
Albitar, Orwa ;
Ballouze, Rama ;
Ooi, Jer Ping ;
Ghadzi, Siti Maisharah Sheikh .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 166
[3]  
[Anonymous], 2021, COR COVID 19 DASHB W
[4]  
[Anonymous], 2020, Republic of Turkey Ministry of Health Corona Table, 202
[5]   COVID-19 mortality risk assessment: An international multi-center study [J].
Bertsimas, Dimitris ;
Lukin, Galit ;
Mingardi, Luca ;
Nohadani, Omid ;
Orfanoudaki, Agni ;
Stellato, Bartolomeo ;
Wiberg, Holly ;
Gonzalez-Garcia, Sara ;
Parra-Calderon, Carlos Luis ;
Robinson, Kenneth ;
Schneider, Michelle ;
Stein, Barry ;
Estirado, Alberto ;
Beccara, Lia ;
Canino, Rosario ;
Dal Bello, Martina ;
Pezzetti, Federica ;
Pan, Angelo .
PLOS ONE, 2020, 15 (12)
[6]   Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study [J].
Di Castelnuovo, Augusto ;
Bonaccio, Marialaura ;
Costanzo, Simona ;
Gialluisi, Alessandro ;
Antinori, Andrea ;
Berselli, Nausicaa ;
Blandi, Lorenzo ;
Bruno, Raffaele ;
Cauda, Roberto ;
Guaraldi, Giovanni ;
My, Ilaria ;
Menicanti, Lorenzo ;
Parruti, Giustino ;
Patti, Giuseppe ;
Perlini, Stefano ;
Santilli, Francesca ;
Signorelli, Carlo ;
Stefanini, Giulio G. ;
Vergori, Alessandra ;
Abdeddaim, Amina ;
Ageno, Walter ;
Agodi, Antonella ;
Agostoni, Piergiuseppe ;
Aiello, Luca ;
Al Moghazi, Samir ;
Aucella, Filippo ;
Barbieri, Greta ;
Bartoloni, Alessandro ;
Bologna, Carolina ;
Bonfanti, Paolo ;
Brancati, Serena ;
Cacciatore, Francesco ;
Caiano, Lucia ;
Cannata, Francesco ;
Carrozzi, Laura ;
Cascio, Antonio ;
Cingolani, Antonella ;
Cipollone, Francesco ;
Colomba, Claudia ;
Crisetti, Annalisa ;
Crosta, Francesca ;
Danzi, Gian B. ;
D'Ardes, Damiano ;
Donati, Katleen de Gaetano ;
Di Gennaro, Francesco ;
Di Palma, Gisella ;
Di Tano, Giuseppe ;
Fantoni, Massimo ;
Filippini, Tommaso ;
Fioretto, Paola .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (11) :1899-1913
[7]   Health outcomes and economic burden of hospitalized COVID-19 patients in the United States [J].
Di Fusco, Manuela ;
Shea, Kimberly M. ;
Lin, Jay ;
Nguyen, Jennifer L. ;
Angulo, Frederick J. ;
Benigno, Michael ;
Malhotra, Deepa ;
Emir, Birol ;
Sung, Anita H. ;
Hammond, Jennifer L. ;
Stoychev, Sophia ;
Charos, Apostolos .
JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) :308-317
[8]   Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study [J].
Du, Rong-Hui ;
Liang, Li-Rong ;
Yang, Cheng-Qing ;
Wang, Wen ;
Cao, Tan-Ze ;
Li, Ming ;
Guo, Guang-Yun ;
Du, Juan ;
Zheng, Chun-Lan ;
Zhu, Qi ;
Hu, Ming ;
Li, Xu-Yan ;
Peng, Peng ;
Shi, Huan-Zhong .
EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
[9]   COVID-19 and comorbidities: Deleterious impact on infected patients [J].
Ejaz, Hasan ;
Alsrhani, Abdullah ;
Zafar, Aizza ;
Javed, Humera ;
Junaid, Kashaf ;
Abdalla, Abualgasim E. ;
Abosalif, Khalid O. A. ;
Ahmed, Zeeshan ;
Younas, Sonia .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (12) :1833-1839
[10]  
Emami A, 2020, ARCH ACAD EMERG MED, V8, DOI 10.22037/aaem.v8i1.600